Gene · 2030
Papers2,306
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,306
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Red Blood Cell Metabolism In Vivo and In Vitro. | Metabolites | 2023 | 37512500 | PubTator, text mining | PubMed |
| Inborn Errors of Purine Salvage and Catabolism. | Metabolites | 2023 | 37512494 | PubTator, text mining | PubMed |
| Interactions of the Anti-SARS-CoV-2 Agents Molnupiravir and Nirmatrelvir/Paxlovid with Human Drug Transporters. | Int J Mol Sci | 2023 | 37510996 | PubTator, text mining | PubMed |
| Therapeutic Targeting of RNA Splicing in Cancer. | Genes (Basel) | 2023 | 37510283 | PubTator, text mining | PubMed |
| Therapeutic Targeting of DNA Replication Stress in Cancer. | Genes (Basel) | 2023 | 37510250 | PubTator, text mining | PubMed |
| A Subset of Non-Small Cell Lung Cancer Patients Treated with Pemetrexed Show 18F-Fluorothymidine "Flare" on Positron Emission Tomography. | Cancers (Basel) | 2023 | 37509378 | PubTator, text mining | PubMed |
| Hub genes, diagnostic model, and predicted drugs in systemic sclerosis by integrated bioinformatics analysis. | Front Genet | 2023 | 37501723 | PubTator, text mining | PubMed |
| Effects of multiple stressors on pancreatic human islets proteome reveal new insights into the pathways involved. | Proteomics | 2023 | 37489002 | PubTator, text mining | PubMed |
| The role of diagnostic, prognostic, and predictive biomarkers in the management of early pancreatic cancer. | J Cancer Res Clin Oncol | 2023 | 37460806 | PubTator, text mining | PubMed |
| How Cryo-EM Has Expanded Our Understanding of Membrane Transporters. | Drug Metab Dispos | 2023 | 37438132 | PubTator, text mining | PubMed |
| Psoriasis Associated Hub Genes Revealed by Weighted Gene Co-Expression Network Analysis. | Cell J | 2023 | 37434459 | PubTator, text mining | PubMed |
| Addressing the Clinical Importance of Equilibrative Nucleoside Transporters in Drug Discovery and Development. | Clin Pharmacol Ther | 2023 | 37404197 | PubTator, text mining | PubMed |
| Retroperitoneal undifferentiated pleomorphic sarcoma with total nephrectomy: a case report and literature review. | Front Surg | 2023 | 37396292 | PubTator, text mining | PubMed |
| Nuclear PLD1 combined with NPM1 induces gemcitabine resistance through tumorigenic IL7R in pancreatic adenocarcinoma. | Cancer Biol Med | 2023 | 37381714 | PubTator, text mining | PubMed |
| Gestational Diabetes-Placental Expression of Human Equilibrative Nucleoside Transporter 1 (hENT1): Is Delayed Villous Maturation an Adaptive Pattern? | Diagnostics (Basel) | 2023 | 37370929 | PubTator, text mining | PubMed |
| Role of Intracellular Drug Disposition in the Response of Acute Myeloid Leukemia to Cytarabine and Idarubicin Induction Chemotherapy. | Cancers (Basel) | 2023 | 37370755 | PubTator, text mining | PubMed |
| Differential expression profiles and functional analysis of long non-coding RNAs in calcific aortic valve disease. | BMC Cardiovasc Disord | 2023 | 37369992 | PubTator, text mining | PubMed |
| In Vitro Interaction of Tetrahydrouridine with Key Human Nucleoside Transporters. | J Pharm Sci | 2023 | 37364771 | PubTator, text mining | PubMed |
| Potential herb‒drug interactions between anti-COVID-19 drugs and traditional Chinese medicine. | Acta Pharm Sin B | 2023 | 37360014 | PubTator, text mining | PubMed |
Human adenovirus DNA polymerase is evolutionarily and functionally associated with human telomerase reverse transcriptase based on in silico molecular characterization that implicate abacavir and zidovudine. | Front Bioinform | 2023 | 37351013 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2030/papers?page=10